[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
[ Tue, Feb 14th 2023 ]: WOPRAI
Silvan Tuerkcan Initiated (TERN) at Buy and Held Target at $17 on, Feb 14th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Silvan Tuerkcan of JMP Securities, Initiated "Terns Pharmaceuticals, Inc." (TERN) at Buy and Held Target at $17 on, Feb 14th, 2023.
Silvan has made no other calls on TERN in the last 4 months.
There are 3 other peers that have a rating on TERN. Out of the 3 peers that are also analyzing TERN, 1 agrees with Silvan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ed Arce of "HC Wainwright & Co." Maintained at Hold with Increased Target to $7 on, Thursday, December 29th, 2022
These are the ratings of the 2 analyists that currently disagree with Silvan
- Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $19 on, Tuesday, February 7th, 2023
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022